Tobacco smoking and tobacco cessation in 2019

 

tt_19bilEN.jpg

Memo, OFDT, 4 p.
April 2020

The 2019 edition of the annual OFDT overview on tobacco describes the repercussions of successive rises in prices of tobacco in the tobacconist network and the continuous increase of the number of people following a treatment to stop smoking. These elements are completed by a report of the results of public surveys carried out in 2018 which witnessed a drop in smoking.

  • On the whole, the total number of tobacco sales is 46 962 tonnes and the decrease in volumes sold in the French tobacconist network reaches 6.6% (on a constant number of delivery days).
  • For the third consecutive year, sales of treatments to help quit smoking have rocketed and now correspond to almost 4.3 million equivalent “treated patients”, that is one third more than in 2018.
  • In parallel, the prevalence of daily smoking has dropped in 2018 among adults (aged between 18 and 75 years old) and secondary school students. In comparison, the number of electronic cigarette users continues to grow among adults, and e-cig experimentation is increasing among adolescents.

Author : Marc-Antoine Douchet

Download the PDF file (517 Ko)

 

 

 

 

 

 

 

 

Drugs in Europe


2020 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2020 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2020

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.